Zimmer Biomet Stock-Based Compensation — Historical Data
Zimmer Biomet (ZBH) stock-based compensation was $90M in FY2025 (-11% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$90M
-11%
2024
$101M
+1%
2023
$100M
-5%
2022
$105M
+38%
2021
$76M
+3%
2020
$74M
-12%
2019
$84M
+29%
2018
$66M
+22%
2017
$54M
-6%
2016
$57M
+23%
2015
$46M
-6%
2014
$49M
+2%
2013
$48M
-12%
2012
$55M
-9%
2011
$60M
-2%
2010
$62M
-18%
2009
$75M
+8%
2008
$70M
-0%
2007
$70M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$25M
Q1 2026
$24M
Q4 2025
$24M
Q3 2025
$25M
Q2 2025
$21M
Q1 2025
$20M
Q4 2024
$21M
Q3 2024
$24M
Q2 2024
$26M
Q1 2024
$29M
Q4 2023
$25M
Q3 2023
$16M
Source: ZBH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.